OPTIMAL v3.2

  • Research type

    Research Study

  • Full title

    Evaluation of the precision and accuracy of international normalised ratio (INR) measurements as assessed by Lumiradx instrument in a point of care setting with multiple operators

  • IRAS ID

    232773

  • Contact name

    Karen Lang

  • Contact email

    karen.lang@lumiradx.com

  • Sponsor organisation

    LumiraDx

  • Duration of Study in the UK

    0 years, 0 months, 26 days

  • Research summary

    A performance evaluation study designed to assess the precision and accuracy of the LumiraDx point of care in vitro diagnostic system. The lumiraDx system consists of a portable diagnostic meter in conjunction with single use analyte test strips, for the quantitative determination of Prothrombin Time as expressed as International Normalised Ratio (INR), as sampled from individuals evaluated for INR at the point of care. Results obtained from the LumiraDx system will be compared to results of a "gold standard" system to assess accuracy, but will not be used to influence patient care in any way during this study.

  • REC name

    East of Scotland Research Ethics Service REC 2

  • REC reference

    17/ES/0161

  • Date of REC Opinion

    30 Jan 2018

  • REC opinion

    Further Information Favourable Opinion